MTPH.L Gross Margin

The Gross Margin of Midatech Pharma PLC (MTPH.L) is 94.91%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

MTPH.L Gross Margin - Historical Value

Date	Value
2021-12-31	94.91%
2020-12-31	94.91%
2019-12-31	-

MTPH.L Gross Margin - Peers Comparison

Ticker	Name	Value
SLN.L	Silence Therapeutics PLC	3133.78%
ADAP	Adaptimmune Therapeutics PLC	99.96%
BCYC	Bicycle Therapeutics PLC	7775.20%
GV.PA	Genomic Vision SA	-165.01%
LIDDS.ST	Lidds AB	-1102.81%
SCS.WA	Stem Cells Spin SA	86.16%
ABNX.PA	Abionyx Pharma SA	18.35%
ALZ.ST	Alzinova AB	-32846.67%
MYOV	Myovant Sciences Ltd	77.68%
IDOGEN.ST	Idogen AB	7775.20%
PROMO.ST	Promore Pharma AB	-124472.22%
ALPAT.PA	Plant Advanced Technologies PAT SA	128.03%
CMPS	Compass Pathways PLC	7775.20%
GEN.WA	Genomed SA	44.96%
GNS.L	Genus PLC	36.68%
ABC.L	Abcam PLC	71.12%
CNTA	Centessa Pharmaceuticals PLC	7775.20%
IMMU.ST	Mendus AB (publ)	7775.20%
VAL.L	ValiRx PLC	85.00%
ACTI.ST	Active Biotech AB publ	100.00%
COMBI.ST	Combigene AB	-14.34%
GUARD.ST	Guard Therapeutics International AB (publ)	100.00%
ALNEV.PA	Neovacs SA	5.49%
EVG.L	Evgen Pharma PLC	-1151.58%
IMCR	Immunocore Holdings PLC	99.12%
ISR.ST	ISR Immune System Regulation Holding AB (publ)	-45046.17%
ALPRE.PA	Predilife SA	97.25%
SENZA.ST	SenzaGen AB	66.89%
SPRINT.ST	Sprint Bioscience AB	56.83%
TOL.ST	Toleranzia AB	1842.86%
RDG.WA	Read Gene SA	93.23%
XINT.ST	Xintela AB	100.00%
AEGIR.ST	Aegirbio AB	47.83%
ALLR.ST	Allarity Therapeutics A/S	-175.91%
MVIR B.ST	Medivir AB	-1470.45%
OXB.L	Oxford Biomedica PLC	41.17%